- Home
- PASG vs LNZA Comparison
PASG vs LNZA Comparison
Compare PASG & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PASG | LNZA |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.3M | 33.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PASG | LNZA |
|---|---|---|
| Price | $9.95 | $14.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $34.50 | $14.00 |
| AVG Volume (30 Days) | ★ 46.5K | 11.3K |
| Earning Date | 11-10-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,876,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $113.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.12 | $11.20 |
| 52 Week High | $20.20 | $274.00 |
Technical Indicators
Market Signals| Indicator | PASG | LNZA |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 42.73 |
| Support Level | $9.72 | $13.37 |
| Resistance Level | $10.71 | $17.30 |
| Average True Range (ATR) | 0.84 | 1.08 |
| MACD | 0.11 | 0.48 |
| Stochastic Oscillator | 73.25 | 55.56 |
Price Performance
Historical ComparisonAbout PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a carbon management company transforming waste carbon into sustainable fuels, fabrics, packaging, and nutrition. Its goal is to advance a circular economy where carbon is reused rather than wasted, reducing reliance on virgin fossil resources and supporting supply chain resilience. The company operates in North America, Europe, Middle East, Africa (EMEA), Asia, and Australia.